Rua Bioscience (NZSE:RUA) OCF Margin %: -113.94% (As of Dec. 2025)


What is Rua Bioscience OCF Margin %?

Rua Bioscience NZSE:RUA OCF Margin % is -113.94% as of Dec. 2025. The stock has 4 warning signs investors should review. Among 961 Drug Manufacturers companies, Rua Bioscience ranks worse than 93.03% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Rua Bioscience's Cash Flow from Operations for the six months ended in Dec. 2025 was NZ$-1.52 Mil. Rua Bioscience's Revenue for the six months ended in Dec. 2025 was NZ$1.33 Mil. Therefore, Rua Bioscience's OCF Margin % for the quarter that ended in Dec. 2025 was -113.94%.

As of today, Rua Bioscience's current OCF Yield % is -23.42%.

The historical rank and industry rank for Rua Bioscience's OCF Margin % or its related term are showing as below:

NZSE:RUA' s OCF Margin % Range Over the Past 10 Years
Min: -28520.83   Med: -2998.91   Max: -179.95
Current: -106.74

During the past 5 years, the highest OCF Margin % of Rua Bioscience was -179.95%. The lowest was -28520.83%. And the median was -2998.91%.

NZSE:RUA's OCF Margin % is ranked worse than
93.03% of 961 companies
in the Drug Manufacturers industry
Industry Median: 9.94 vs NZSE:RUA: -106.74

Rua Bioscience OCF Margin % Related Terms

Rua Bioscience OCF Margin % Historical Data

* Premium members only.

The historical data trend for Rua Bioscience's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rua Bioscience OCF Margin % Chart

Rua Bioscience Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
OCF Margin %
0.00 -28,520.83 -1,653.63 -4,344.19 -179.95

Rua Bioscience Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -12,541.18 -2,326.09 -279.97 -94.98 -113.94

NZSE:RUA vs ZTS, UTHR, VTRS: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Rua Bioscience's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rua Bioscience OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rua Bioscience's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Rua Bioscience's OCF Margin % falls into.


Rua Bioscience OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Rua Bioscience's OCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-2.719/1.511
=-179.95 %

Rua Bioscience's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.52/1.334
=-113.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -113.94% mean?
Rua Bioscience (NZSE:RUA) has a OCF Margin % of -113.94% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Rua Bioscience and its competitors. According to the industry distribution chart, Rua Bioscience ranks #894 out of 961 companies in the Drug Manufacturers industry, placing it in the top 93%.
Is Rua Bioscience's OCF Margin % too high?
Rua Bioscience's current OCF Margin % is -113.94%. Based on the distribution chart, Rua Bioscience ranks #894 out of 961 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Rua Bioscience's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Rua Bioscience ranks #894 out of 961 companies for OCF Margin %. This places Rua Bioscience in the lower half of its industry. The industry median OCF Margin % is 9.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Rua Bioscience and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rua Bioscience's current OCF Margin % is -113.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rua Bioscience stock overvalued right now?
Rua Bioscience (NZSE:RUA) has a current OCF Margin % of -113.94%. The current OCF Margin % is -113.94%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Rua Bioscience (NZSE:RUA), the current OCF Margin % is -113.94% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rua Bioscience Business Description

Address 704 Te Araroa Road, RD3, Ruatoria, NZL, 4083
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany, and New Zealand.